EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1

Juyeong Hong, Pinpin Sui, Ying Li, Kerryn Y Xu, Ji-Hoon Lee, Juan Wang, Shi Chen, Peng Zhang, Noah Wingate, Asra Noor, Yaxia Yuan, Robert Hromas und 13 weitere

Cell Stem Cell · 2025

DOI: 10.1016/j.stem.2025.01.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Stem Cell, 2025. Verfasst von Juyeong Hong und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Proto-Oncogene Proteins, Trans-Activators, Nuclear Proteins. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) is an aggressive hematopoietic malignancy characterized by the blockage of myeloid cell differentiation and uncontrolled proliferation of immature myeloid cells. Here, we show that paraspeckle component 1 (PSPC1) is aberrantly overexpressed and associated with poor survival in AML patients. Using human AML cells and mouse models, we demonstrate that PSPC1 is not required for normal hematopoiesis, but it is critical and essential for AML cells to maintain their leukemic characteristics. PSPC1 loss induces robust differentiation, suppresses proliferation, and abolishes leukemogenesis in diverse AML cells. Mechanistically, PSPC1 exerts a pro-leukemia effect by regulating a unique leukemic transcription program via cooperative chromatin binding with PU.1 and activation of tumor-promoting genes, including NDC1, which is not previously implicated in AML. Our findings uncover a unique and crucial role of PSPC1 dependency in AML and highlight its potential as a promising therapeutic target for AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteProto-Oncogene ProteinsTrans-ActivatorsNuclear ProteinsRNA-Binding ProteinsGene Expression Regulation, LeukemicTranscription, GeneticCarcinogenesisHumansAnimalsMiceCell Line, TumorCell ProliferationCell DifferentiationProto-Oncogene Protein Spi-1

Stichwörter der Autor:innen

AMLNDC1PSPC1PU.1hematopoiesisleukemia

Substanzen

Proto-Oncogene ProteinsTrans-ActivatorsNuclear ProteinsRNA-Binding ProteinsProto-Oncogene Protein Spi-1

Autor:innen und Institutionen

  • Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
  • Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
  • Department of Biochemistry & Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
  • Department of Medicine, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA; Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
  • Department of Medicine, Columbia Center for Human Development and Stem Cell Therapies, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.

Förderung

  • NICHD NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • National Heart Lung and Blood Institute Division of Intramural Research
  • National Cancer Institute
  • National Institute of Child Health and Human Development
  • University of California, Los Angeles

Zitieren

APA

Hong, J., Sui, P., Li, Y., Xu, K. Y., Lee, J. H., Wang, J., Chen, S., Zhang, P., Wingate, N., Noor, A., Yuan, Y., Hromas, R., Zhou, H., Hamamoto, K., Su, R., Yin, C. C., Ye, F., Quesada, A. E., Chen, J., …, & Xu, M. (2025). PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1. Cell Stem Cell. https://doi.org/10.1016/j.stem.2025.01.010

Vancouver

Hong J, Sui P, Li Y, Xu KY, Lee JH, Wang J, et al. PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1. Cell Stem Cell. 2025. doi:10.1016/j.stem.2025.01.010

BibTeX
@article{Hong2025,
  author = {Hong, Juyeong and Sui, Pinpin and Li, Ying and Xu, Kerryn Y and Lee, Ji-Hoon and Wang, Juan and Chen, Shi and Zhang, Peng and Wingate, Noah and Noor, Asra and Yuan, Yaxia and Hromas, Robert and Zhou, Hongwei and Hamamoto, Karina and Su, Rui and Yin, C Cameron and Ye, Fengxi and Quesada, Andrés E and Chen, Jianjun and Huang, Suming and Zhou, Daohong and You, M James and Yang, Feng-Chun and Wang, Jianlong and Xu, Mingjiang},
  title = {PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1},
  journal = {Cell Stem Cell},
  year = {2025},
  doi = {10.1016/j.stem.2025.01.010}
}
Kostenlos starten →